These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 26458006

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Salivary antibody levels in adolescents in response to a meningococcal serogroup C conjugate booster vaccination nine years after priming: systemically induced local immunity and saliva as potential surveillance tool.
    Stoof SP, van der Klis FR, van Rooijen DM, Bogaert D, Trzciński K, Sanders EA, Berbers GA.
    Vaccine; 2015 Jul 31; 33(32):3933-9. PubMed ID: 26100925
    [Abstract] [Full Text] [Related]

  • 3. Meningococcal serogroup C immunogenicity, antibody persistence and memory B-cells induced by the monovalent meningococcal serogroup C versus quadrivalent meningococcal serogroup ACWY conjugate booster vaccine: A randomized controlled trial.
    van Ravenhorst MB, van der Klis FRM, van Rooijen DM, Knol MJ, Stoof SP, Sanders EAM, Berbers GAM.
    Vaccine; 2017 Aug 24; 35(36):4745-4752. PubMed ID: 28668575
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Timing of an adolescent booster after single primary meningococcal serogroup C conjugate immunization at young age; an intervention study among Dutch teenagers.
    Stoof SP, van der Klis FR, van Rooijen DM, Knol MJ, Sanders EA, Berbers GA.
    PLoS One; 2014 Aug 24; 9(6):e100651. PubMed ID: 24963638
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Persistence of serum bactericidal antibody one year after a booster dose of either a glycoconjugate or a plain polysaccharide vaccine against serogroup C Neisseria meningitidis given to adolescents previously immunized with a glycoconjugate vaccine.
    de Whalley PC, Snape MD, Kelly DF, Banner C, Lewis S, Diggle L, John TM, Yu LM, Omar O, Borkowski A, Pollard AJ.
    Pediatr Infect Dis J; 2011 Nov 24; 30(11):e203-8. PubMed ID: 21673612
    [Abstract] [Full Text] [Related]

  • 11. Immunity against Neisseria meningitidis serogroup C in the Dutch population before and after introduction of the meningococcal c conjugate vaccine.
    de Voer RM, Mollema L, Schepp RM, de Greeff SC, van Gageldonk PG, de Melker HE, Sanders EA, Berbers GA, van der Klis FR.
    PLoS One; 2010 Aug 13; 5(8):e12144. PubMed ID: 20730091
    [Abstract] [Full Text] [Related]

  • 12. Five-year antibody persistence and safety following a booster dose of combined Haemophilus influenzae type b-Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine.
    Tejedor JC, Merino JM, Moro M, Navarro ML, Espín J, Omeñaca F, García-Sicilia J, Moreno-Pérez D, Ruiz-Contreras J, Centeno F, Barrio F, Cabanillas L, Muro M, Esporrin C, De Torres MJ, Caubet M, Boutriau D, Miller JM, Mesaros N.
    Pediatr Infect Dis J; 2012 Oct 13; 31(10):1074-7. PubMed ID: 22828645
    [Abstract] [Full Text] [Related]

  • 13. Antibody persistence after serogroup C meningococcal conjugate immunization of United Kingdom primary-school children in 1999-2000 and response to a booster: a phase 4 clinical trial.
    Perrett KP, Winter AP, Kibwana E, Jin C, John TM, Yu LM, Borrow R, Curtis N, Pollard AJ.
    Clin Infect Dis; 2010 Jun 15; 50(12):1601-10. PubMed ID: 20459323
    [Abstract] [Full Text] [Related]

  • 14. Use of saliva to monitor meningococcal vaccine responses: proposing a threshold in saliva as surrogate of protection.
    van Ravenhorst MB, van der Klis FRM, van Rooijen DM, Sanders EAM, Berbers GAM.
    BMC Med Res Methodol; 2019 Jan 05; 19(1):1. PubMed ID: 30611213
    [Abstract] [Full Text] [Related]

  • 15. Meningococcal serogroup C polysaccharide specific memory B cells, directly enumerated by labeled polysaccharide, are not affected by age at vaccination.
    Henneken M, Burdin N, Thoroddsen E, Sigurdardottir ST, Trannoy E, Jonsdottir I.
    Vaccine; 2010 Feb 25; 28(9):2097-103. PubMed ID: 20056181
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of De-O-acetylated meningococcal C polysaccharide-tetanus toxoid conjugate vaccine in infancy: reactogenicity, immunogenicity, immunologic priming, and bactericidal activity against O-acetylated and De-O-acetylated serogroup C strains.
    Richmond P, Borrow R, Findlow J, Martin S, Thornton C, Cartwright K, Miller E.
    Infect Immun; 2001 Apr 25; 69(4):2378-82. PubMed ID: 11254596
    [Abstract] [Full Text] [Related]

  • 17. Long-term persistence of immunity and B-cell memory following Haemophilus influenzae type B conjugate vaccination in early childhood and response to booster.
    Perrett KP, John TM, Jin C, Kibwana E, Yu LM, Curtis N, Pollard AJ.
    Clin Infect Dis; 2014 Apr 25; 58(7):949-59. PubMed ID: 24403544
    [Abstract] [Full Text] [Related]

  • 18. Immunogenicity, Safety and Antibody Persistence of a Booster Dose of Quadrivalent Meningococcal ACWY-tetanus Toxoid Conjugate Vaccine Compared with Monovalent Meningococcal Serogroup C Vaccine Administered Four Years After Primary Vaccination Using the Same Vaccines.
    Vesikari T, Forsten A, Bianco V, Van der Wielen M, Miller JM.
    Pediatr Infect Dis J; 2015 Dec 25; 34(12):e298-307. PubMed ID: 26780033
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.